{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:30:05Z","timestamp":1792445405103,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.ejso.2019.11.498","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T02:35:33Z","timestamp":1573526133000},"page":"522-526","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"PA","title":["Neoadjuvant chemotherapy in patients with breast cancer: Does response in the breast predict axillary node response?"],"prefix":"10.1016","volume":"46","author":[{"given":"C.","family":"Morgan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.D.","family":"Stringfellow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Rolph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kothari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.E.","family":"Pinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Hamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.R.","family":"Sever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejso.2019.11.498_bib1","article-title":"Preoperative chemotherapy for women with operable breast cancer","volume":"18","author":"Mieog","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejso.2019.11.498_bib2","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1200\/JCO.2011.38.8595","article-title":"Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes","volume":"30","author":"von Minckwitz","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2019.11.498_bib3","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1245\/s10434-015-4404-8","article-title":"Pathological complete response in neoadjuvant treatment of breast cancer","volume":"22","author":"Cortazar","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.11.498_bib4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jnci\/djj158","article-title":"Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial","volume":"98","author":"Mansel","year":"2006","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ejso.2019.11.498_bib5","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.ejso.2019.11.498_bib6","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1002\/cncr.25152","article-title":"Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer","volume":"116","author":"Dominici","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2019.11.498_bib7","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.ejso.2019.11.498_bib8","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","article-title":"Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection","volume":"34","author":"Caudle","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2019.11.498_bib9","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/cncr.27995","article-title":"Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer. Translational Breast Cancer Research Consortium trial 017","volume":"119","author":"De Los Santos","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2019.11.498_bib10","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/SLA.0000000000000551","article-title":"Factors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for breast cancer patients enrolled in ACOSOG Z1071 (Alliance)","volume":"261","author":"Boughey","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2019.11.498_bib11","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2019.11.498_bib12","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1245\/s10434-015-4527-y","article-title":"Improving the accuracy of axillary lymph node surgery in breast cancer with ultrasound-guided wire localization of biopsy proven metastatic lymph nodes","volume":"22","author":"Plecha","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.11.498_bib13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1148\/radiol.2019190014","article-title":"Predicting axillary response to neoadjuvant chemotherapy: breast MRI and US in patients with node-positive breast cancer","volume":"293","author":"Kim","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.ejso.2019.11.498_bib14","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1200\/JCO.2007.15.0235","article-title":"Preoperative chemotherapy: updates of national surgical adjuvant breast and bowel project protocols B-18 and B-27","volume":"26","author":"Rastogi","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2019.11.498_bib15","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/SLA.0000000000002953","article-title":"The clinical significance of breast-only and node-only pathologic complete response (pCR) after neoadjuvant chemotherapy (NACT): a review of 20,000 breast cancer patients in the national cancer data base (NCDB)","volume":"268","author":"Fayanju","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2019.11.498_bib16","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.3747\/co.20.1294","article-title":"Axillary lymph node status, adjusted for pathologic complete response in breast and axilla after neoadjuvant chemotherapy, predicts differential disease-free survival in breast cancer","volume":"20","author":"Zhang","year":"2013","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ejso.2019.11.498_bib17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4137\/BCBCR.S33163","article-title":"Relevance of pathological complete response after neoadjuvant therapy for breast cancer","volume":"10","author":"Pennisi","year":"2016","journal-title":"Breast Cancer (Auckl)"},{"key":"10.1016\/j.ejso.2019.11.498_bib18","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","article-title":"Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection","volume":"34","author":"Caudle","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2019.11.498_bib19","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1245\/s10434-015-5052-8","article-title":"Axillary staging after neoadjuvant chemotherapy for breast cancer: a pilot study combining sentinel lymph node biopsy with radioactive seed localization of pre-treatment positive axillary lymph nodes","volume":"23","author":"Diego","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.11.498_bib20","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1148\/radiol.11110814","article-title":"Breast cancer: evaluation of response to neoadjuvant chemotherapy with 3.0-T MR imaging","volume":"261","author":"Chen","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.ejso.2019.11.498_bib21","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1200\/JCO.2010.31.1258","article-title":"Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype","volume":"29","author":"Loo","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2019.11.498_bib22","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","article-title":"Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis","volume":"384","author":"Cortazar","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2019.11.498_bib23","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S1470-2045(07)70278-4","article-title":"Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial","volume":"8","author":"Krag","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2019.11.498_bib24","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1200\/JCO.2014.57.8401","article-title":"Axillary ultrasound after neoadjuvant chemotherapy and its impact on sentinel lymph node surgery: results from the American college of surgeons oncology group Z1071 trial (alliance)","volume":"33","author":"Boughey","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2019.11.498_bib25","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.breast.2017.05.015","article-title":"The use of ultrasound in the clinical re-staging of the axilla after neoadjuvant chemotherapy (NACT)","volume":"35","author":"Peppe","year":"2017","journal-title":"Breast"},{"key":"10.1016\/j.ejso.2019.11.498_bib26","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.2214\/AJR.17.18323","article-title":"MRI, clinical examination, and mammography for preoperative assessment of residual disease and pathologic complete response after neoadjuvant chemotherapy for breast cancer: ACRIN 6657 trial","volume":"210","author":"Scheel","year":"2018","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ejso.2019.11.498_bib27","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/SLA.0b013e3181c5dda3","article-title":"MRI-model to guide the surgical treatment in breast cancer patients after neoadjuvant chemotherapy","volume":"251","author":"Straver","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2019.11.498_bib28","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2214\/AJR.17.18295","article-title":"Axillary ultrasound identifies residual nodal disease after chemotherapy: results from the American college of surgeons oncology group Z1071 trial (alliance)","volume":"210","author":"Le-Petross","year":"2018","journal-title":"AJR Am J Roentgenol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798319314428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798319314428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:32:31Z","timestamp":1760059951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798319314428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0748798319314428"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2019.11.498","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neoadjuvant chemotherapy in patients with breast cancer: Does response in the breast predict axillary node response?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2019.11.498","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}